disease 816 words KG: ent-dise-3772ef23
Contents

Progressive Bulbar Palsy (PBP)

Disease Info
PrevalenceApproximately 1-2 per 100,000 individuals annually[@chio2013]
Age of onsetTypically 50-70 years[@logroscino2010]
GenderSlight male predominance (1.3-1.5:1)[@manera2020]
Motor neuron degenerationLoss of motor neurons in the brainstem nuclei (hypoglossal nucleus, nucleus ambiguus, facial nucleus)
Bunina bodiesSmall intraneuronal inclusions characteristic of ALS
Corticospinal tract involvementOften associated with upper motor neuron signs
SOD1 mutationsAccount for 15-20% of familial ALS cases
FUS mutationsAssociated with aggressive bulbar-onset disease
TARDBP mutationsTDP-43 gene mutations
DysarthriaProgressive slurred speech, initially affecting consonants, then vowels
DysphagiaDifficulty swallowing, initially for solids, then liquids
DysphoniaHoarse, nasal, or weak voice
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (4)

Cross-Seeding Prevention Strategy
Score: 0.69
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Cryptic Exon Silencing Restoration
Score: 0.53
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.47

Related Analyses (5)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · completed
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.